Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders

Addictive Behaviors

Volumn 36, Issue 5, 2011, Pages 439-447

  Brown, Clayton H ^a,b   Bennett, Melanie E ^a,b   Li, Lan ^a,b   Bellack, Alan S ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

Author keywords

Co occurring disorders; Dual disorders; Schizophrenia; Treatment engagement

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE;

ADULT; ALCOHOLISM; ARTICLE; BRIEF QUALITY OF LIFE INVENTORY; CANNABIS ADDICTION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG ALCOHOL SECTION OF THE ADDICTION SEVERITY INDEX; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EDUCATIONAL STATUS; EMOTION; FAMILY RELATION; FEMALE; HEROIN DEPENDENCE; HUMAN; LEGAL ASPECT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; MOTIVATION; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE FEELING; PREDICTION; PRISONER; QUALITY OF LIFE INDEX; SCHIZOPHRENIA; SCREENING; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; TEMPTATION TO USE DRUGS SCALE; TREATMENT DURATION; UNIVERSITY OF RHODE ISLAND CHANGE ASSESSMENT SCALE; VETERAN;

ADULT; BALTIMORE; FAMILY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MOTIVATION; OUTPATIENTS; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

EID: 79951852036     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2010.12.001     Document Type: Article

References (68)

1. Altman D.G. Practical statistics for medical research 1991, Chapman & Hall, New York.
2. Appleby L., Luchins D.J., Dyson V., Fanning T., Freels S. Predischarge linkage and after-care contact among dually-diagnosed public psychiatric patients. Journal of Nervous and Mental Disease 2001, 189:265-267.
3. Baker A., Lewin T., Reichler H., Clancy R., Carr V., Garrett R., et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica 2002, 106:233-240.
4. Bellack A.S., Bennett M.E., Gearon J.S., Brown C.H., Yang Y. A randomized clinical trial of a new behavioral intervention for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 2006, 63:426-432.
5. Bellack A.S., DiClemente C.C. Treating substance abuse among patients with schizophrenia. Psychiatric Services 1999, 50:75-80.
6. Bennett M.E., Bellack A.S., Brown C.H., DiClemente C. Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders. Addictive Behaviors 2009, 34(10):806-814.
7. Bennett M.E., Gjonbalaj S. The problem of dual diagnosis. Adult Psychopathology and Diagnosis 2007, 34-77. John Wiley and Sons, New York. 5th ed. M. Hersen, S. Turner, D. Beidel (Eds.).
8. Blanchard J.J., Mueser K.T., Bellack A.S. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin 1998, 24:413-424.
9. Bogenschutz M.P., Siegfreid S.L. Factors affecting engagement of dual diagnosis patients in outpatient treatment. Psychiatric Services 1998, 49:1350-1352.
10. Brunette M.F., Drake R.E. Gender differences in patients with schizophrenia and substance abuse. Comprehensive Psychiatry 1997, 38:109-116.
11. Carey K.B., Carey M.P., Maisto S.A., Purnine D.M. The feasibility of enhancing psychiatric outpatients' readiness to change their substance use. Psychiatric Services 2002, 53:602-608.
12. Clark R.E., Ricketts S.K., McHugo G.J. Legal system involvement and costs for persons in treatment for severe mental illness and substance use disorders. Psychiatric Services 1999, 50:641-647.
13. Claus R.E., Kindleberger L.R. Engaging substance abusers after centralized assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs 2002, 34:25-31.
14. Claus R.E., Kindleberger L.R., Dugan M.C. Predictors of attrition in a longitudinal study of substance abusers. Journal of Psychoactive Drugs 2002, 34:69-74.
15. Comfort M., Loverro J., Kaltenbach K. A search for strategies to engage women in substance abuse treatment. Social Work in Health Care 2000, 31:59-70.
16. Compton M.T., Goulding S.M., Gordon T.L., Weiss P.S., Kaslow N.J. Family-level predictors and correlates of the duration of untreated psychosis in African American first episode patients. Schizophrenia Research 2009, 115:338-345.
17. Compton M.T., Rudisch B.E., Craw J., Thompson T., Owens D.A. Predictors of missed first appointments at community mental health centers after psychiatric hospitalization. Psychiatric Services 2006, 57:531-537.
18. Copello A.G., Templeton L., Velleman R. Family interventions for drug and alcohol misuse: Is there a best practice?. Current Opinion in Psychiatry 2006, 19:271-276.
19. Corrigan P.W., Liberman R.P., Engel J.D. From noncompliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 1990, 41:1203-1211.
20. Cragg J., Uhler R. The demand for automobiles. Canadian Journal of Economics 1970, 3:386-406.
21. Curran G.M., Stecker T., Han X., Booth B.M. Individual and program predictors of attrition from VA substance use treatment. Journal of Behavioral Health Services Research 2007, 36(1):25-34.
22. Daley D.C., Zuckoff A. Improving compliance with the initial outpatient session among discharged inpatient dual diagnosis clients. Social Work 1998, 43:470-473.
23. DeMarce J.M., Lash S.J., Stephens R.S., Grambow S.C., Burden J.L. Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment. Addictive Behaviors 2008, 33:1104-1112.
24. DiClemente C.C., Carbonari J.P., Montgomery R.P.G., Hughes S.O. The alcohol abstinence self-efficacy scale. Journal of Studies on Alcohol 1994, 55:141-148.
25. Dixon L.B., Dickerson F., Bellack A.S., Bennett M., Dickinson D., Goldberg R.W., et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophrenia Bulletin 2009, 36(1):48-70.
26. Drake R.E., Mueser K.T., Brunette M.F., McHugo G.J. A review of treatments for clients with severe mental illness and co-occurring substance use disorder. Psychiatric Rehabilitation Journal 2004, 27:360-374.
27. Drapalski, A. L., Bennett, M. E., & Bellack, A. S. (in press). Gender differences in substance use, consequences, motivation to change, and treatment seeking in people with serious mental illness. Substance Use and Misuse.
28. El-Mallakh R.S., James T., Khan T., Katz M., McGovern B., Nair S., et al. Follow-up after inpatient psychiatric hospitalization with partial control of the system responsiveness variable. Psychiatry 2004, 67(3):294-298.
29. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for axis I DSM-IV 1994, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
30. Fischer E.P., McSweeney J.C., Pyne J.M., Williams D.K., Naylor A.J., Blow F.C., et al. Influence of family involvement and substance use on sustained utilization of services for schizophrenia. Psychiatric Services 2008, 59:902-908.
31. Garnick D.W., Horgan C.M., Chalk M. Performance measures for alcohol and other drug services. Alcohol Research and Health 2006, 29:19-26.
32. Guydish J., Werdegar D., Sorensen J.L., Clark W., Acampora A. Drug abuse day treatment: A randomized clinical trial comparing day and residential treatment programs. Journal of Consulting and Clinical Psychology 1998, 66:280-289.
33. Harvey C.A., Jeffreys S.E., McNaught A.S., Blizard R.A., King M.B. The Camden schizophrenia surveys. III: Five-year outcome of a sample of individuals from a prevalence survey and the important of social relationships. International Journal of Social Psychiatry 2007, 53:340-356.
34. Hellemann G., Conner B.T., Anglin M.D., Longshore D. Seeing the trees despite the forest: Applying recursive partitioning to the evaluation of drug treatment retention. Journal of Substance Abuse Treatment 2009, 36:59-64.
35. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
36. Killaspy H., Banerjee S., King M., Lloyd M. Prospective controlled study of psychiatric outpatient nonattendance: Characteristics and outcomes. British Journal of Psychiatry 2000, 176:160-165.
37. Kreyenbuhl J., Nossel I.R., Dixon L.B. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: A review of the literature. Schizophrenia Bulletin 2009, 35(4):696-703.
38. Kruse G.R., Rohland B.M., Wu X. Factors associated with missed first appointments at a psychiatric clinic. Psychiatric Services 2002, 53:1173-1176.
39. Lash S.J. Increasing participation in substance abuse aftercare treatment. American Journal on Drug Abuse 1998, 24:31-36.
40. Lash S.J., Blosser S.L. Increasing adherence to substance abuse aftercare group therapy. Journal of Substance Abuse Treatment 1999, 16:55-60.
41. Lehman A.F. Evaluating Quality of Life for Persons with Severe Mental Illness: Assessment toolkit 1995, The evaluation center at health services research institute, Cambridge, Massachusetts.
42. Lehman A.F., Dixon L.B., Kernan E., DeForge B.R., Postrado L.T. A randomized trial of assertive community treatment for homeless persons with severe mental illness. Archives of General Psychiatry 1997, 54:1038-1043.
43. McCaul M.E., Svikis D.S., Moore R.D. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence 2001, 62:9-17.
44. McConnaughy E.A., DiClemente C.C., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: A follow-up report. Psychotherapy 1989, 26:494-503.
45. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 1992, 9:199-213.
46. Miller W.R., Rollnick S. Motivational interviewing: Preparing people to change addictive behaviors 1991, Guilford Press, New York.
47. Miner C.R., Rosenthal R.N., Hellerstein D.J., Muenz L.R. Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Archives of General Psychiatry 1997, 54:706-712.
48. Mueser K.T., Bennett M., Kushner M.G. Epidemiology of substance use disorders among persons with chronic mental illnesses. Double Jeopardy: Chronic Mental Illness and Substance Use Disorders 1995, 3:9-25. Harwood Academic Publishers, Longhorne, PA. A.F. Lehman, L.B. Dixon (Eds.).
49. Mueser K.T., Glynn S.M., Cather C., Zarate R., Fox L., Feldman J., et al. Family intervention for co-occurring substance use and severe psychiatric disorders: Participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addictive Behaviors 2009, 34:867-877.
50. Nagelkerke N. A note on a general definition of the coefficient of determination. Biometrika 1991, 78:691-692.
51. Nidecker M., Bennett M.E., Gjonbalag-Marovic S., Rachbeisel J., Bellack A.S. Relationships among motivation to change, barriers to care, and substance-related negative consequences in people with dual disorders. Journal of Dual Diagnosis 2009, 5(3-4):375-391.
52. Nidecker M., DiClemente C., Bennett M.E., Bellack A.S. Application of the Transtheoretical model of change: psychometric properties of leading measures in patients with co-occurring drug abuse and severe mental illness. Addictive Behaviors 2008, 33(8):1021-1030.
53. Nosé M., Barbui C., Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine 2003, 33:1149-1160.
54. O'Brien A., Fahmy R., Singh S.P. Disengagement from mental health services. Social Psychiatry and Psychiatric Epidemiology 2009, 44:558-568.
55. Opler L.A., Kay S.R., Lindenmayer J.P., Fiszbein A. Structured clinical interview for the positive and negative syndrome scale 1992, Multi-Health Systems, New York.
56. Pantalon M.V., Swanson A.J. Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behavior 2003, 17:91-97.
57. Peeters F.P., Bayer H. "No-show" for initial screening at a community mental health centre: Rate, reasons, and further help-seeking. Social Psychiatry and Psychiatric Epidemiology 1999, 34:323-327.
58. Prochaska J.O., Diclemente C.C., Norcross J.C. In search of how people change: Applications to addictive behaviors. Addictive Behaviors: Readings on Etiology, Prevention, and Treatment 1992, 671-696. American Psychological Association, Washington, DC. A.G. Marlatt, G.R. VandenBos (Eds.).
59. Project MATCH Research Group Matching alcoholism treatments to client heterogeneity: Project MATCH post-treatment drinking outcomes. Journal of Studies on Alcohol 1997, 58:7-29.
60. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association 1990, 264:2511-2518.
61. Sekerka R., Goldsmith R.J., Brandewie L., Somoza E. Treatment outcome of an outpatient treatment program for dually-diagnosed veterans: The Cincinnati Veterans Affairs Medical Center. Journal of Psychoactive Drugs 1999, 31:85-94.
62. Siqueland L., Crits-Christoph P., Gallop B., Gastfriend D., Lis J., Frank A., et al. Who starts treatment: Engagement in the NIDA collaborative cocaine treatment study. American Journal on Addiction 2002, 11:10-23.
63. Smith T.E., Burgos J., Dexter V., Norcott J., Pappas S.V., Shuman E., et al. Best practices for improving engagement of clients in clinic care. Psychiatric Services 2010, 61(4):343-345.
64. Swanson A.J., Pantalon M.V., Cohen K.R. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed clients. Journal of Nervous and Mental Disease 1999, 187:630-635.
65. Swartz M.S., Wagner H.R., Swanson J.W., Stroup T.S., McEvoy J.P., Canive J.M., et al. Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. Journal of Nervous and Mental Disease 2006, 194:164-172.
66. Winokur G., Turvey C., Akiskal H., Coryell W., Solomon D., Leon A., et al. Alcoholism and drug abuse in three groups - Bipolar I, unipolars, and their acquaintances. Journal of Affective Disorders 1998, 50:81-89.
67. Wolpe P.R., Gorton G., Serota R., Sanford B. Predicting compliance of dual diagnosis inpatients with aftercare treatment. Hospital and Community Psychiatry 1993, 44:45-49.
68. Ziedonis D.M., Trudeau K. Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based treatment model. Schizophrenia Bulletin 1997, 23:229-238.